OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. Mediterr J Hematol Infect Dis 2015, 7 (1), e2015003. https://doi.org/10.4084/mjhid.2015.003.